Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Definitive Radiotherapy in High-Risk NMIBC
NCT07873333Not yet recruiting
- Sponsor
- Assiut University
- Start
- Oct 2026
- Primary completion
- Dec 2026
01
Overview
Randomised, open-label trial in non-muscle-invasive bladder cancer (NMIBC) (2 arms), sponsored by Assiut University. Primary endpoint: Complete Response Rate at 6 months. Planned start Oct 2026; status: not yet recruiting.
02
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT07873333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07873333.